Listar por autor "Fernández, Victoria"
Mostrando ítems 1-4 de 4
-
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández-Fernández, Óscar; Fernández, Victoria; Alonso, Antonio; Caballero-González, Abelardo
; Luque, Gloria; Bravo, Mariano; León-Martín, Antonio; Mayorga Mayorga, Cristobalina; Leyva-Fernández, Laura; De Ramón Garrido, Enrique[et al.] (Springer, 2004-04)
Background The human leukocyte antigen (HLA) class II DR2 haplotype (DRB1*1501, DQA1*0102, DQB1*0602) has been associated with multiple sclerosis (MS) in all ethnic groups and very strongly in Caucasians. Aim To investigate ... -
Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months.
Oliver-Martos, Begoña; Fernández, Óscar; Orpez, Teresa; Alvarenga, Marco Papais; Pinto-Medel, María Jesús; Guerrero, Miguel; León, Antonio; López-Madrona, José Carlos; Maldonado-Sánchez, Rafael; García-León, Juan Antonio; Luque, Gloria; Fernández, Victoria; Leyva-Fernández, Laura[et al.] (SAGE, 2011-03)
Natalizumab is a monoclonal antibody shown to be highly effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). Patients treated with natalizumab can develop antibodies directed against this agent that ... -
Presurgical 3D gait analysis findings in four children with spastic cerebral palsy
Smith-Fernández, Víctor Manuel; Postigo-Pozo, Sergio; Postigo, María José; Prado-Novoa, María; Núñez, María José; Ros, Bienvenido; Fernández, Victoria[et al.] (2014-01-07)
Introduction: Children with spastic palsy present usually with an altered gait pattern. This pattern presents various superimposed alterations, due to spasticity and due to musculosqueletal deformities; some of them are ... -
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.
Fernández Fernández, Óscar; Papais Alvarenga, Marcos; Guerrero, Miguel; León, Antonio; Alonso, Ana; López-Madrona, Jose Carlos; Leyva-Fernández, Laura; Oliver-Martos, Begoña; De Ramón, Enrique; Luque, Gloria; Fernández, Victoria[et al.] (Sage Publications, 2010-11-18)
Background: Little is known about how the level of disability at the start of treatment with natalizumab affects its efficacy. Objectives: The aim of this study was to investigate the effect of natalizumab on relapses in ...